PURE Bioscience, Inc. revenue by segment PURE

PURE Bioscience, Inc. splits its revenue into 5 lines in its filings. The largest line in fiscal 2026, which ended Jul 31, 2026 was PURE Hard Surface at $2.2 million, 94% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line
FY 2026
Jul 31, 2026
FY 2025
Jul 31, 2025
FY 2024
Jul 31, 2024
FY 2023
Jul 31, 2023
FY 2022
Jul 31, 2022
FY 2021
Jul 31, 2021
FY 2020
Jul 31, 2020
FY 2019
Jul 31, 2019
FY 2018
Jul 31, 2018
FY 2017
Jul 31, 2017
Revenue
2
2
2
2
2
4
7
2
2
—
PURE Hard Surface
2
+9.3%
share 94.1%
2
+7.4%
share 90.6%
2
+4.0%
share 94.7%
2
share 95.2%
—
—
—
—
—
—
Pure Hard Surface
—
—
—
—
1
-58.0%
share 80.8%
4
share 90.8%
—
—
—
—
Silverion
—
—
—
—
0
+135.0%
share 17.0%
0
share 3.4%
—
—
—
—
Sil Verion
0
-34.0%
share 5.8%
0
+109.3%
share 9.2%
0
+14.1%
share 4.9%
0
share 4.5%
—
—
—
—
—
—
Royalty
0
-25.0%
share 0.1%
0
-50.0%
share 0.2%
0
+33.3%
share 0.4%
0
-85.0%
share 0.3%
0
-82.5%
share 2.2%
0
share 5.8%
—
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. More on our methodology.

Company profile

Industry
Miscellaneous Chemical Products (SIC 2890)
Listed as
PURE (OTC)
Fiscal year ends
July 31
Incorporated in
DE
Headquarters
El Cajon, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1006028
Former names
PURE BIOSCIENCE (until Mar 17, 2011); INNOVATIVE MEDICAL SERVICES (until Sep 2, 2003)

Other Miscellaneous Chemical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.